Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 10:39 am Purchase | 2024-09-30 | 13G | Rentokil Initial plc RTO | JANUS HENDERSON GROUP PLC JHG | 135,517,488 5.400% | 135,517,488![]() (New Position) | Filing History |
| 2024-11-14 10:37 am Purchase | 2024-09-30 | 13G | Revvity, Inc. RVTY | JANUS HENDERSON GROUP PLC JHG | 6,335,302 5.100% | 3,104,733![]() (+96.10%) | Filing History |
| 2024-11-14 10:36 am Purchase | 2024-09-30 | 13G | NeoGenomics, Inc. NEO | JANUS HENDERSON GROUP PLC JHG | 6,603,180 5.200% | 3,131,140![]() (+90.18%) | Filing History |
| 2024-11-14 10:33 am Purchase | 2024-09-30 | 13G | Immunome, Inc. IMNM | JANUS HENDERSON GROUP PLC JHG | 3,488,121 5.800% | 3,488,121![]() (New Position) | Filing History |
| 2024-11-14 10:31 am Purchase | 2024-09-30 | 13G | Caesars Entertainment, Inc. CZR | JANUS HENDERSON GROUP PLC JHG | 12,609,243 5.900% | 3,225,781![]() (+34.38%) | Filing History |
| 2024-11-14 10:29 am Purchase | 2024-09-30 | 13G | Aramark ARMK | JANUS HENDERSON GROUP PLC JHG | 15,714,443 6.000% | 15,714,443![]() (New Position) | Filing History |
| 2024-11-14 10:28 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | JANUS HENDERSON GROUP PLC JHG | 6,813,163 6.800% | 6,813,163![]() (New Position) | Filing History |
| 2024-11-14 10:26 am Purchase | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | JANUS HENDERSON GROUP PLC JHG | 3,956,878 6.900% | 3,956,878![]() (New Position) | Filing History |
| 2024-11-14 10:25 am Sale | 2024-09-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -775,525![]() (Position Closed) | Filing History |
| 2024-11-14 10:24 am Purchase | 2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX | JANUS HENDERSON GROUP PLC JHG | 4,799,352 7.100% | 4,799,352![]() (New Position) | Filing History |
| 2024-11-14 10:02 am Sale | 2024-09-30 | 13G | Skye Bioscience, Inc. SKYE | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -1,727,680![]() (Position Closed) | Filing History |
| 2024-11-14 10:00 am Sale | 2024-09-30 | 13G | Compass Therapeutics, Inc. CMPX | JANUS HENDERSON GROUP PLC JHG | 1,843,286 1.300% | -5,804,454![]() (-75.90%) | Filing History |
| 2024-11-14 09:59 am Sale | 2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -2,380,667![]() (Position Closed) | Filing History |
| 2024-11-14 09:56 am Purchase | 2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA | JANUS HENDERSON GROUP PLC JHG | 236,116 0.700% | 236,116![]() (New Position) | Filing History |
| 2024-11-14 09:53 am Purchase | 2024-09-30 | 13G | Constellium SE CSTM | JANUS HENDERSON GROUP PLC JHG | 6,152,955 84.000% | 6,152,955![]() (New Position) | Filing History |
| 2024-11-14 09:50 am Sale | 2024-09-30 | 13G | Catalent, Inc. CTLT | JANUS HENDERSON GROUP PLC JHG | 201,264 0.100% | -13,048,075![]() (-98.48%) | Filing History |
| 2024-11-14 09:40 am Sale | 2024-09-30 | 13G | Sarepta Therapeutics, Inc. SRPT | JANUS HENDERSON GROUP PLC JHG | 4,358,511 4.600% | -987,274![]() (-18.47%) | Filing History |
| 2024-11-14 07:46 am Sale | 2024-09-30 | 13G | Janus Henderson Group plc JHG | Silchester International Investors LLP | 5,734,436 3.600% | -9,154,233![]() (-61.48%) | Filing History |
| 2024-11-06 3:26 pm Unchanged | 2024-10-31 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,682,275 13.500% | 0 (Unchanged) | Filing History |
| 2024-11-06 3:13 pm Purchase | 2024-10-31 | 13G | Monopar Therapeutics Inc. MNPR | JANUS HENDERSON GROUP PLC JHG | 562,482 10.900% | 562,482![]() (New Position) | Filing History |

